摘要
为观察便塞通合剂和莫沙必利治疗慢传输型便秘的临床疗效，我们用便塞通合剂和莫沙必利联合治疗慢传输型便秘35例（治疗组），单用莫沙必利治疗慢传输型便秘30例（对照组），对疗效进行对比分析。结果显示，治疗组痊愈18例，显效11例，有效6例，无无效病例，总有效率为100％；对照组痊愈9例，显效11例，有效8例，无效2例，总有效率93．3％。两组总有效率差异有统计学意义，P〈0．05。治疗组在症状改善方面亦明显优于对照组，P〈0．05。结果表明，便塞通合剂和莫沙必利联合治疗慢传输型便秘效果确切，值得临床进一步推广应用。
For the objective of observing therapeutic effect of Biansaitong mixture（a traditional prescription of drugs） and mosapride for slow transit constipation（STC） the 35 patients of the study group received this therapy ; while other 30 patients with STC received mosapride only（the control group）. As results, 18 cases were cured,11 cases was notably improved, 6 cases were improved and notbody got no improvement, the general improvement rate was 100% in the study group ; while in the control group,the respective number was 9,11,8 and 2,the general improvement rate was 93.3%（ P 〈0.05）. The symptoms improved in the study group was better than that in the control group. It is revealed that the combined medication of Biansaitong mixture and mosapride can bring about a definite therapeutic results in the treatment of STC.
出处
《中国肛肠病杂志》
2009年第8期44-45,共2页
Chinese Journal of Coloproctology
关键词
慢传输型便秘
便塞通合剂
莫沙必利
疗效
Slow transit constipation
Biansaitong mixture
Mosapride
Therapeutic efficacy
